2002

Sinocare was established

2004

Launched the first SXT-1 blood glucose meter, and developed test strips with automatic capillary action for sample collection

2007

Engaged in China-Cuba biotechnology cooperation and realized large-scale export to Cuba and Latin American markets

2012

Sinocare went public on SZSE (Shenzhen Stock Exchange), the first listed company of blood glucose meter in China

2015

Developed China’s first truly hospital-grade blood glucose meter: Gold-Accu

2016

Acquisition of largest US based BGM manufacturer Nipro Diagnostic Inc.(Now renamed as Trividia Health Inc.) and PTS Diagnostics Inc.

2017

Sinocare Hospital diabetes management system was implemented

2019

AGEscan, a non-invasive diabetes risk screening product, opening a new entrance to the whole course management of diabetes

2020

iPOCT standardization laboratory is marketed officially in CMEF Shanghai

2022

Sinocare Qingshan Park - the new iPOCT industrial park was put into use

2023

The Continuous Glucose Monitoring (CGMS) product-Sinocare iCan officially obtained the product registration certificate